These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20089008)

  • 1. Patent foramen ovale closure in post-CVA/TIA patients: psychological distress, quality of life and optimism.
    Cohen M; Daniela M; Lorber A
    Int J Clin Pract; 2010 Jan; 64(2):182-7. PubMed ID: 20089008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of psychological symptoms in post-cryptogenic cerebral-vascular accident (CVA) and/or transient ischemic attack (TIA) patients who have undergone foramen ovale closure, and in post-CVA patients.
    Cohen M; Telman G; Mansoor D; Lorber A
    Arch Gerontol Geriatr; 2011; 52(3):e152-5. PubMed ID: 21075464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life after percutaneous closure of patent foramen ovale in patients after cryptogenic stroke compared to a normative sample.
    Mirzada N; Ladenvall P; Hansson PO; Eriksson P; Taft C; Dellborg M
    Int J Cardiol; 2018 Apr; 257():46-49. PubMed ID: 29422265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale.
    Hornung M; Bertog SC; Franke J; Id D; Taaffe M; Wunderlich N; Vaskelyte L; Hofmann I; Sievert H
    Eur Heart J; 2013 Nov; 34(43):3362-9. PubMed ID: 23842846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.
    Wahl A; Jüni P; Mono ML; Kalesan B; Praz F; Geister L; Räber L; Nedeltchev K; Mattle HP; Windecker S; Meier B
    Circulation; 2012 Feb; 125(6):803-12. PubMed ID: 22238228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous closure of patent foramen ovale in cryptogenic embolism.
    Meier B; Kalesan B; Mattle HP; Khattab AA; Hildick-Smith D; Dudek D; Andersen G; Ibrahim R; Schuler G; Walton AS; Wahl A; Windecker S; Jüni P;
    N Engl J Med; 2013 Mar; 368(12):1083-91. PubMed ID: 23514285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure.
    Faggiano P; Frattini S; Piovesana P; Lorusso R; Chiari E; Scolari F; Padovani A; Cas LD
    Int J Cardiol; 2012 Apr; 156(1):47-52. PubMed ID: 21112103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism.
    Cifarelli A; Musto C; Parma A; Pandolfi C; Pucci E; Fiorilli R; De Felice F; Nazzaro MS; Violini R
    Int J Cardiol; 2010 Jun; 141(3):304-10. PubMed ID: 19178959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent foramen ovale treatment strategy: an Italian large prospective study.
    Alushi B; Biasco L; Orzan F; Omedé P; Sciuto F; Moretti C; Belli R; Defilippi G; Barisone G; Cerrato P; Gaita F
    J Cardiovasc Med (Hagerstown); 2014 Oct; 15(10):761-8. PubMed ID: 24978876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of cryptogenic stroke or TIA in patients with patent foramen ovale successfully treated by using different kind of percutaneous occluder devices: five-year follow-up.
    de Cillis E; Acquaviva T; Basile DP; Cipriani F; Bortone AS
    Minerva Cardioangiol; 2010 Aug; 58(4):425-31. PubMed ID: 20938409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
    Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
    Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation following device closure of patent foramen ovale.
    Burow A; Schwerzmann M; Wallmann D; Tanner H; Sakata T; Windecker S; Meier B; Delacrétaz E
    Cardiology; 2008; 111(1):47-50. PubMed ID: 18239392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent events after percutaneous closure of patent foramen ovale.
    Wallenborn J; Bertog SC; Franke J; Steinberg DH; Majunke N; Wilson N; Wunderlich N; Sievert H
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):541-6. PubMed ID: 22707325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of patent foramen ovale closure for prevention on recurrent stroke or transient ischemic attack in selected patients with cryptogenic stroke.
    Kim M; Kim S; Moon J; Oh PC; Park YM; Shin DH; Lee YB; Lee JY; Hwang HY; Kang WC
    J Interv Cardiol; 2018 Jun; 31(3):368-374. PubMed ID: 28833599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
    Ussia GP; Cammalleri V; Mulè M; Scarabelli M; Barbanti M; Scardaci F; Mangiafico S; Immè S; Capodanno D; Tamburino C
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):607-14. PubMed ID: 19360875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of cerebral embolism after interventional closure of symptomatic patent foramen ovale or atrial septal defect: a diffusion-weighted MRI and neuron-specific enolase-based study.
    Oktay Tureli H; Ungan I; Tureli D; Demir B; Pirhan O; Bayrak HI; Caglar IM; Karakaya O; Inci E
    J Invasive Cardiol; 2013 Oct; 25(10):519-24. PubMed ID: 24088426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New onset atrial fibrillation after patent foramen ovale closure.
    Staubach S; Steinberg DH; Zimmermann W; Wawra N; Wilson N; Wunderlich N; Sievert H
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):889-95. PubMed ID: 19626689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism.
    Spies C; Khandelwal A; Timmemanns I; Kavinsky CJ; Schräder R; Hijazi ZM
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):966-70. PubMed ID: 18942060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
    Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
    Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of atrial fibrillation after transcatheter closure of patent foramen ovale in patients with or without cryptogenic stroke.
    Bronzetti G; D'Angelo C; Donti A; Salomone L; Giardini A; Maria Picchio F; Boriani G
    Int J Cardiol; 2011 Jan; 146(1):17-21. PubMed ID: 19487038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.